Panel: Understanding Regulatory Compliance and Operational Landmines That Often Disrupt Lab Sales and Closings
A Panel discussion featuring:
David Gee, Christopher Jahnle, Elizabeth Sullivan, Esq., Diana Voorhees, MA, MLS, SH, CLCP, CPCO
Panel: Best Paths to Attracting Capital and Crafting Effective Growth Strategies that Support a High-Multiple Sales Valuation for Genetic Testing Labs
A Panel discussion featuring:
Melissa Butterworth, Bryan Firestone, Emily Johnson, JD, and Myles Standish
Panel: Best Paths to Attracting Capital and Crafting Effective Growth Strategies that Support a High-Multiple Sales Valuation for Genetic Testing Labs
Panel: Bringing Your Hospital Lab or Independent Lab to Market for the Optimal Price: Timing, Pitfalls, Showing the Best ‘Face’
A Panel discussion featuring:
Christal Contini, JD, Jeff Downs, Gary Huff, Christopher Jahnle, and Ven Aduana, MD
Panel: Bringing Your Hospital Lab or Independent Lab to Market for the Optimal Price: Timing, Pitfalls, Showing the Best ‘Face’
Panel: What’s Changing with Buyers of Hospital Labs, Independent Labs, Genetic labs, and Pathology Groups
Presented by:
Clarisa Blattner
Best Practices in Genetic Test Coding, Billing, Collections, with Prior-Authorization insights
Panel: What’s Changing with Buyers of Hospital Labs, Independent Labs, Genetic labs, and Pathology Groups
A Panel discussion featuring:
Anil Asnani, Richard Cooper, JD, John Runk, and Matthew Urbanek
Panel: What’s Changing with Buyers of Hospital Labs, Independent Labs, Genetic labs, and Pathology Groups
